R.PR
REGISTERED-PRINCIPAL REGISTER
11/16/2021
Back to search
Official data from USPTO
ROYALTY PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ROYALTY PHARMA
ST13
US500000090178440Class
35, 36
Filing
90178440
Registration
6558516
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
11/16/2021
Trademark type
Word
Nice classes
35, 36
Filing date
09/14/2020
Registration date
11/16/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/16/2021
Last transaction
11/16/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
12/31/1996
First use in commerce
12/31/1996
Drawing code
4
Owner type
16
Owner location
New York, NY, US
Examiner
O'BRIEN, JENNIFER
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
RP Management, LLC
Representatives
David C. Lee AKIN GUMP STRAUSS HAUER & FELD LLP
Technical classification
Nice Classes
Class 35Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Acquisition and merger consultationidentifying and acquiring revenue streams and monetization opportunities from the sale of biopharmaceutical productspharmaceuticalsmedical diagnosticsdevicesequipment
Class 36
Financial servicescapital and fund investment services; investment management and investment advisory services; identifying and acquiring revenue streams and monetization opportunities from the sale of biopharmaceutical productspharmaceuticalsmedical diagnosticsdevicesequipmentfinancial analysis in the nature of financial modelling of the future value of biopharmaceutical royalties and complex structured financing
Publications
History of USPTO decisions and trademark events.
19 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/31/2021
PUBO
PUBLISHED FOR OPPOSITION
08/31/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/11/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/23/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
07/14/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/14/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
07/14/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/14/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/20/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/19/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/19/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
03/12/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/04/2021
GNRT
NON-FINAL ACTION E-MAILED
02/04/2021
CNRT
NON-FINAL ACTION WRITTEN
02/04/2021
DOCK
ASSIGNED TO EXAMINER
01/26/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/21/2020
NWAP
NEW APPLICATION ENTERED
09/17/2020
Continuous trademark protection
Get notified about every new filing that threatens ROYALTY PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.